Literaturverzeichnis zum Titelthema
Prävention in der Gastroenterologie; Was ist gesichert - was ist Mythos?
Bayerisches Ärzteblatt 5/2013, Seite 208 ff.
von Dr. Vincens Weingart und Professor Dr. Hans-Dieter Allescher
Seite 1 von 3
1. Altenhofen L et al. Wissenschaftliche Begleitung der Früherkennungs-Koloskopie.6.
Jahresbericht (2008) Zentralinstitut für die Kassenärztliche Versorgung in der Bundesrepublik Deutschland, Berlin 2010
2. Wong YN, Meropol NJ, Speier W, Sargent D, Goldberg RM, Beck JR. Cost implications of new treatments for advanced colorectal cancer.Cancer 2009; 115 (10): 2081-91
3. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008; 103: 1541–9
4. Guth S, Leise U, Gocke C, Herborn CU, Galach A, Bamberger CM.; Ultrasound versus MRI in preventive examinations - a retrospective analysis of 833 patients; Ultraschall Med. 2012 Dec;33(7):E202-9
5. Vasen HF, Möslein G, Alonso A, et al.; Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer), J Med Genet. 2007 Jun; 44(6):353-62. Epub 2007 Feb 27. Review
6. Tonus, Carolin; Sellinger, Markus; Koss, Konrad; Neupert, Gero: Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysis; World Journal of Gastroenterology, 2012 August 14; 18 (30):4004 – 4011
7. Möslein G et al; Analysis of the statistical value of various commercially available stool tests - a comparison of one stool sample in correlation to colonoscopy; Dtsch Med Wochenschr. 2010 Mar;135(12):557-62.
8. Classen M, Maar Ch. Europe against Colorectal Cancer. Outlining a pan-European colon cancer screening program Z Gastroenterol 2008; 46: S1-S54
9. Akerkar GA et al. Patient experience and preferences toward colon cancer screening: a comparison of virtual colonoscopy and conventional colonoscopy. Gastrointest Endosc 2001;
54 (3): 310–315
10. Pickhardt PJ et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003; 349 (23): 2191–2200 (EBM-Grad: I b) 11. Weston AP, Badr AS, Ruth S et al. Prospective multivariate analysis of clinical, endoscopic,
and histologicaal factors predicitve of development of Barrett’s multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 1999; 94: 3413–3419
12. Van der Burgh A, Dees J, Hop WC et al. Oesophageal cancer is an uncommon cause of death in patients with Barrett’s oesophagus. Gut 1996; 39: 5–8
13. Koop H et al. Gastro_sophageale Refluxkrankheit – Ergebnisse einer evidenzbasierten Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs- und
Stoffwechselkrankheiten; Z Gastroenterol 2005; 43: 163–164 ;
Seite 2 von 3
14. Hamashima C, Shibuya D, Yamazaki H et al. The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 2008; 38 (4): 259–267
15. de Vries AC, van Grieken NC, Looman CW et al. Gastric cancer risk in patients with
premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008; 134 (4): 945–52
16. Poulsen AH, Christensen S, McLaughlin JK et al. Proton pump inhibitors and risk of gastric cancer: a population-based cohort study. Br J Cancer 2009; 100 (9): 1503–1507
17. Feng GS, Ma JL,Wong BC et al. Celecoxib-related gastroduodenal ulcer and cardiovascular events in a randomized trial for gastric cancer prevention. World J Gastroenterol 2008; 14 (28): 4535–4539
18. Homma T, Tsuchiya R. The study of the mass screening of persons without symptoms and of the screening of outpatients with gastrointestinal complaints or icterus for pancreatic cancer in Japan, using CA 19-9 and elastase-1 or ultrasonography. Int J Pancreatol 1991; 9: 119–124 19. Canto MI, Goggins M, Hruban RH et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 2006; 4: 766–781; quiz 665
20. Wiegand J, Berg T.; The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis; Dtsch Arztebl Int. 2013 Feb;110(6):85-91.
21. Birkner BR. Evidence-based prevention of colorectal carcinoma. Dtsch MedWochenschr 2003;
128 (49): 2598–2603
22. Citarda F et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001; 48 (6): 812–815
23. Ahsan H et al. Family history of colorectal adenomatous polyps and increased risk for colorectal cancer. Ann Intern Med 1998; 128 (11): 900–905
24. Church JM et al. Teenagers with familial adenomatous polyposis: what is their risk for colorectal cancer? Dis Colon Rectum 2002; 45 (7): 887–889
25. Vasen HF et al. Decision analysis in the surgical treatment of patients with familial
adenomatous polyposis: a Dutch-Scandinavian collaborative study including 659 patients. Gut 2001; 49 (2): 231–235
26. Knudsen AL, Bisgaard ML, Bulow S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer 2003; 2 (1): 43–55
27. Jarvinen HJ et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000; 118 (5): 829–834
28. Dove-Edwin I et al. The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal
carcinoma. Cancer 2002; 94 (6): 1708–1712
29. Karlen P et al. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 1998; 42 (5): 711–714
Seite 3 von 3
30. Eaden J et al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 2000; 14 (2): 145–153
31. Lin J, Zhang SM, Cook NR, Rexrode KM, Liu S, Manson JE, Lee IM, Buring JE.; Dietary intakes of fruit, vegetables, and fiber, and risk of colorectal cancer in a prospective cohort of women (United States). Cancer Causes Control. 2005 Apr;16(3):225-33.
32. Wu K et al. Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst 2002; 94 (6): 437–446
33. Konings EJ et al. Intake of dietary folate vitamers and risk of colorectal carcinoma: results from The Netherlands Cohort Study. Cancer 2002; 95 (7): 1421–1433
34. Larsson SC, Håkansson N, Giovannucci E, Wolk A. Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men. J Natl Cancer Inst. 2006 Mar 15;98(6):407-13.
35. Norat T et al. Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer 2002; 98 (2): 241–256
36. Brown LM. Epidemiology of alcohol-associated cancers. Alcohol 2005; 35: 161–168
37. Testino G, Borro P, Ancarani O, Sumberaz A. Human carcinogenesis and alcohol in hepato- gastroenterology.Eur Rev Med Pharmacol Sci. 2012 Apr;16(4):512-8.
38. Hassan C, Rex DK, Cooper GS, Zullo A, Launois R, Benamouzig R. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis.Gut. 2012 Aug;61(8):1172-9
39. Harris RE, Beebe-Donk J, Doss H et al. Aspirin, ibuprofen, and other non-steroidal anti- inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review). Oncol Rep 2005; 13: 559–583
40. Friedenreich CM, Neilson HK, Lynch BM; State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer 2010 Sep;46(14):2593-604
41. Berrington de Gonzalez A, Spencer EA, Bueno-de-Mesquita HB et al. Anthropometry, physical activity, and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2006; 15: 879–885
42. Friedenreich CM, Orenstein MR. Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 2002; 132 (11 Suppl): 3456S–3464S
43. Giacosa A et al. Energy intake, overweight, physical exercise and colorectal cancer risk. Eur J Cancer Prev 1999; 8 (Suppl 1): S53–S60
44. Chiu BC, Lynch CF, Cerhan JR et al. Cigarette smoking and risk of bladder, pancreas, kidney, and colorectal cancers in
